Emel Gürcüoğlu

Dr. Emel Gürcüoğlu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2025 in Current Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
BTBilge Tuna
Bilge Tuna
EGEmel Gürcüoğlu
Emel Gürcüoğlu
Purpose of Review: Deep neck infections (DNI) are serious infections that can have fatal complications and may have unpredictable outcomes despite parenteral antibiotic therapy. We aimed to investigate the prognostic factors determinig the success of empirical parenteral antibiotic therapy when it is employed together with surgical drainage in patients diagnosed with DNI. Recent Findings: A retrospective study was conducted on 112 patients who underwent surgical drainage due to DNI between September 15, 2019, and September 15, 2024 at the Otorhinolaryngology Department of our hospital. 77 patients with complete blood counts and culture results were included in the study. Complications, including necrotizing fasciitis (on admission) and tracheotomy (within the first 48 h), occurred in 9.1% of cases. 38% of patients who were treated with empirical Primary Group Antibiotic combinations (penicillins, cephalosporins, quinolones, clindamycin, metronidazol) required a switch to Secondary Group Antibiotic combinations (vancomycin, teicoplanin, linezolid, carbapenems, piperacillin-tazobactam). There were significant differences in terms of abscess extent, neutrophil count and duration of hospitalization between patients requiring treatment change and those for whom empirical treatment was sufficient. Complications were significantly higher in patients with multi-region abscesses, higher systemic immune-inflammatory (SII) index and neutrophil counts. ( p < 0.05). Summary: In patients with multi-region abscessess and an SII index cut-off value of 1616.5 according to ROC analysis, initiation of broad-spectrum Secondary Group Antibiotic combinations together with surgical drainage of abscesses can effectively reduce complication rates and shorten the duration of hospital stay.

1 August 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
EGEmel Gürcüoğlu
Emel Gürcüoğlu
GÇGülbahar Çalışkan
Gülbahar Çalışkan
MBMÜZEYYEN tuğçe BENLİ
MÜZEYYEN tuğçe BENLİ
DTDemet Timur
Demet Timur
Background: In catheter-related candidemia, a true catheter-source infection is often difficult to distinguish from a catheter that merely marks critical illness. Our primary aim was to identify predictors of 30-day mortality; secondary aims were to characterize species-specific patterns of persistent candidemia, its prognostic meaning within the host immune–inflammatory context, and the relationship between echinocandin therapy and secondary bacterial bloodstream infection (BSI). Methods: We retrospectively reviewed 89 consecutive episodes of catheter-related candidemia at Bursa City Hospital (2021–2025). Catheter association required Candida spp. growth in concurrent catheter and peripheral blood cultures. The primary endpoint was 30-day mortality; persistent candidemia (≥72 h) and secondary bacterial BSI on days 3–30 were evaluated as exploratory endpoints. Raw MIC values were retrospectively reinterpreted according to EUCAST v12.1 breakpoints (effective 10 April 2026). Results: Thirty-day mortality was 53.9% (48/89). The multivariable model was significant (LR χ2 = 12.12, df = 4, p = 0.017; Nagelkerke R2 = 0.170); NLR was not significantly associated with mortality (OR = 1.061, 95% CI 1.00–1.13, p = 0.064). Catheter removal, initial echinocandin therapy, and persistent candidemia were not independent predictors, though catheter retention was associated with higher mortality on univariable analysis (83.3%; p = 0.033). Persistent candidemia occurred in 51.7% of episodes, most notably with C. parapsilosis and C. auris. The NLR-persistence interaction was not formally significant, but mortality was higher when both co-occurred (66.7% vs. 36.4%; OR = 3.50, p = 0.075). Secondary BSI occurred in 28.4% of episodes and was more frequent in the echinocandin group (39% vs. 20%; p = 0.062); sensitivity analyses did not change the main findings. Conclusions: Mortality could not be explained by antifungal choice alone; these findings are exploratory. Host response, source control, species distribution, survival time, and device exposure are possible contributing factors warranting evaluation in prospective studies.

10 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
EGEmel Gürcüoğlu
Emel Gürcüoğlu
BTBilge Tuna
Bilge Tuna
HOHATİCE ORTAC
HATİCE ORTAC
VGVildan Gursoy
Vildan Gursoy
Objective: We aimed to retrospectively evaluate patients presenting with advanced human immunodeficiency virus (HIV) infection and AIDS-defining conditions following the pandemic, and to examine the occurrence of immune reconstitution inflammatory syndrome (IRIS) after antiretroviral therapy (ART) initiation. In addition, we sought to present our clinical experience. Materials and Methods: Between 2021 and 2025, we retrospectively reviewed 12 ART-naïve adults with advanced HIV infection and complete medical records. Demographic, immunological, and virological parameters, opportunistic infections, IRIS types, and treatment responses were recorded. Results: IRIS developed in all 11 patients (100%) who initiated ART. The median time to IRIS onset was 49 days (range: 20–213). Unmasking IRIS occurred in 63.6% of cases, while paradoxical IRIS accounted for 36.4%. Clinical manifestations included tuberculosis, cytomegalovirus infection, cryptococcosis, toxoplasmosis, Kaposi sarcoma, and lymphoma. Corticosteroid therapy was required in 63.6% of patients. Overall mortality was 33.3%, most frequently associated with cryptococcal meningitis, Pneumocystis jirovecii pneumonia, and Kaposi sarcoma. Conclusion: In our study, the high rates of IRIS and mortality observed among patients with advanced HIV infection and a substantial burden of AIDS-defining illnesses may represent an expected consequence of delayed presentation and increased antigen load. However, the single-center, retrospective design and the limited sample size restrict the generalizability of these findings. Therefore, prospective multicenter studies are needed to more clearly define early markers that may predict the development of IRIS. Clinical trial number: not applicable

23 September 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
DTDemet Timur
Demet Timur
EGEmel Gürcüoğlu
Emel Gürcüoğlu
EÖEmre Özkarataş
Emre Özkarataş
TBTuğba Bozdemir
Tuğba Bozdemir
Local species distribution and antifungal susceptibility are important for empirical candidemia management. We retrospectively evaluated patients with Candida-positive blood cultures from August 2019 to May 2024. Episodes were defined using a 30-day window; species distribution and susceptibility were analysed at the episode–species level and outcomes at the patient level. Among 566 patients, 605 episodes and 637 episode–species isolates were identified. Non-albicans Candida accounted for 59.7%; C. albicans (40.3%) and C. parapsilosis (34.2%) predominated. Of 217 C. parapsilosis isolates tested, 66 (30.4%) were fluconazole-susceptible, 58 (26.7%) were susceptible dose-dependent, and 93 (42.9%) were resistant. Recurrent candidemia occurred in 37 patients and documented microbiological persistence in 128 (22.6%); persistence was more frequent when the index culture included C. parapsilosis (27.6% vs. 20.1%; OR 1.52, 95% CI 1.01–2.28). Among 32 patients with a shared species in the initial and first recurrent episodes, newly detected resistance occurred in three, all involving fluconazole-resistant C. parapsilosis. Thirty-day all-cause mortality was 57.4%; older age, ICU care, mechanical ventilation, and solid malignancy were independently associated with higher mortality. These findings suggest that empirical reliance on fluconazole may be inappropriate in settings with similar resistance patterns and support species-level identification, repeat blood cultures, and episode-specific susceptibility testing.

23 June 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
EGEmel Gürcüoğlu
Emel Gürcüoğlu
Background/Objectives: This preliminary, single-centre study evaluated infectious diseases consultation (IDC) patterns as indicators of hospital workflow and care complexity, aiming to characterise routinely available variables that may inform future organisational research and EHR-based clinical decision support development. Methods: In this retrospective study, 39,275 IDC requests from 16,430 patients were analysed using hospital information management system records. Paediatric patients and specialised immunosuppressed patient units were excluded. Request volumes, diagnostic categories, consultation purposes, and factors associated with in-hospital mortality were evaluated. Multivariable logistic regression models were constructed separately for two hospital blocks. Results: A total of 39,275 IDC records for 16,430 unique patients were reviewed. Mean consultation access time was 82.2 ± 64.3 min. Requests originated from surgical clinics (43.8%), followed by intensive care units (37.6%) and medical/internal clinics (18.6%). Pneumonia was the most common indication (30.5%), followed by unspecified infections (25.4%) and skin/soft tissue infections (17.2%). Consultation objectives included treatment, diagnostic assessment, and clinical guidance as non-mutually exclusive components. Significant block-level differences were observed in consultation timing, ICU-related consultation, diagnostic profiles, consultation purposes, and mortality. Age and ICU-related consultation were independently associated with mortality in both blocks, whereas consultation access time and COVID-19 diagnosis showed block-specific associations. Conclusions: IDC patterns may reflect not only diagnostic demand but also case severity, ICU-related care, consultation timing, and hospital location. As a preliminary single-centre study, these hypothesis-generating findings highlight the importance of integrating clinical, organisational, and contextual variables in future prospective, multi-centre studies aimed at developing EHR-based decision-support models. External validation, incorporation of comorbidity indices and microbiological data, and assessment of explainability are required before clinical implementation.